MEDICAL CANNABIS LEGALISATION
| THE MAIN PROVISIONS OF THE LEGISLATION WHICH IS UNDER DISCUSSION BEFORE THE HOUSE OF THE REPRESENTATIVES FOR THE LEGALISATION OF THE IMPORTATION AND/OR PRODUCTION AND/OR CULTIVATION OF PHARMACEUTICAL CANNABIS
The purpose of the proposed legislation is to amend the Drugs and Psychotropic Substances Act of 1977 to 2016, in order to add additional provisions allowing the regulation of imports of cannabis and cannabis seeds into the Republic. Moreover, the Drugs and Psychotropic Substances (Pharmaceutical Cannabis) Regulations of 2017 (“Regulations”) will regulate among others:
(a) the cultivation, production, importation and exportation of pharmaceutical cannabis and its use for the conduct of scientific research for medical purposes, for the preparation of galenical products by pharmacies for medical or pharmaceutical production,
(b) the free provision of pharmaceutical cannabis to eligible patients.
Persons eligible to apply for a License to produce Pharmaceutical Cannabis
In particular, the draft regulations stipulate that natural persons who should be adults and have their habitual residence in the Republic or in another State Member State, as well as legal entities formed under the laws of the Republic or of another Member State, which have a registered office or place of employment in the Republic and whose staff and directors are all adults are eligible to apply for a license.
Moreover, the potential applicants shall have at least five years of experience in the cultivation and production of pharmaceutical cannabis in the world market. The competent authority, will grant the right to file applications for two Producer licenses. The said license will be valid for a period of up to 15 years.
For more information as to this contact Stelios Americanos & Co LLC on the following emails: |